Category Archives: Population(s)

The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: A systematic review

2023

PURPOSE: Toxoplasma gondii is a parasite that is widely distributed around the globe and can cause brain inflammation, particularly in immunosuppressed patients such as those diagnosed with human immunodeficiency virus...

Coronavirus (COVID-19) and sexualised drug use among men who have sex with men: A systematic review

2023

Drug-related harms, including harms from sexualised drug use (SDU), are disproportionately experienced by sexual and gender minority people, relative to their majority counterparts. Chemsex, a type of SDU practiced mainly...

Post-exposure prophylaxis against blood-borne viral infections among health care workers: A bibliometric analysis

2022

Background: Health care workers face a wide range of chemical, physical, and biological occupational hazards in their jobs. Objective: The present study aimed to investigate research trends on post-exposure prophylaxis (PEP) against...

Gay community involvement and the sexual health behaviors of sexual minority men: A systematic review and directions for future research

2023

AbstractConsiderable research has examined how involvement in gay-affiliated communities is associated with sexual health behaviors in sexual minority men (i.e., gay, bisexual, and other men who have sex with men),...

Best practices to increase engagement and retention in hepatitis C care among people who use drugs

2023

Key take-home messages

Doxycycline prophylaxis for the prevention of bacterial sexually transmitted infections (STIs)

2023

Key take-home messages

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: A global mapping of service delivery

2023

BACKGROUND: The World Health Organization (WHO) recommends oral pre-exposure prophylaxis (PrEP) for all people at substantial risk of HIV as part of combination prevention. The extent to which this recommendation...

Does engagement in HIV care affect screening, diagnosis, and control of noncommunicable diseases in sub-Saharan Africa? A systematic review and meta-analysis

2023

OBJECTIVE: Low- and middle-income countries are facing a growing burden of noncommunicable diseases (NCDs). Providing HIV treatment may also provide opportunities to increase access to NCD services in under-resourced environments....

Multimodality imaging in HIV-associated cardiovascular complications: A comprehensive review

2023

Human immunodeficiency virus (HIV) infection is a leading cause of mortality and morbidity worldwide. The introduction of antiretroviral therapy (ART) has significantly reduced the risk of developing acquired immune deficiency...

Prevalence of Mycoplasma genitalium infection among HIV PrEP users: A systematic review and meta-analysis

2023

Objectives: To summarise the prevalence of Mycoplasma genitalium (MG) and antibiotic-resistant MG infection among HIV pre-exposure prophylaxis (PrEP) users. Methods: We searched MEDLINE, Embase, Web of Science and Global Index Medicus up to 30...

Tools for screening and measuring anxiety among women living with HIV of reproductive age: A scoping review

2023

Emerging evidence suggests that women living with HIV (WLWH) may experience higher rates of anxiety than men living with HIV and women living without HIV. To date, relatively little knowledge...

Association between integrase strand transfer inhibitor use with insulin resistance and incident diabetes mellitus in persons living with HIV: A systematic review and meta-analysis

2023

Whether integrase strand transfer inhibitors (INSTIs) are associated with a higher risk of incident type 2 diabetes mellitus (DM) than other antiretroviral therapies (ART) needs to be established. MEDLINE, Embase,...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!